Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

43% Revenue Contribution of Leading Manufacturers

The sustained release excipients market is largely dominated by local manufactures who are competing on the basis of pricing in the market. The fragmented nature of the market decreases the profitability of the business. However, growing awareness about sustained release excipients and lack of test specificity and sensitivity for sustained release excipients manufactured by local companies have increased the revenue opportunities for the global manufacturers in pharmaceutical excipients.

Companies, such as BASF Corporation, Ashland Global Holdings Inc. and The Dow Chemical Company hold more than 42.8% revenue share in the global sustained release excipients market. The companies operating in the sustained release excipients market are collaborating with local distributors to increase the penetration of their products in the sustained release excipients market.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Increment of Diseases Across the Globe

The prevalence of chronic as well as acute diseases is increasing across the globe. For the treatment of these diseases, doctors prescribe medicines. Medicines usually contain excipients along with the active pharmaceutical ingredients. A huge demand for medicines is witnessed because of increasing prevalence of chronic diseases. They are high in demand in Asia Pacific because of huge volume in this region.

Sustained release excipients release the drug slowly so that it reaches the target site. An excipient can be used in many ways. Due to this fact it is in great demand. Sustained release excipients reduce the indirect cost associated with conventional excipients.

Abusive Consumption of Drugs (Pain Killers) Increasing the Incidence of Chronic Diseases Across North America

Sustained release formulations are gaining popularity as they help in maintaining patient-safety through reduced number of medicine dosages, but having increased drug efficacy. From a market point of view, reduced doses improve treatment compliance, which could help higher unit sales and so their revenues. Furthermore, from the patient point of view, better therapeutic outcomes are expected due to improved drug tolerance and efficacy leading to lower switching costs and greater physician loyalty.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Vertical Integration of Sustained Release Excipients Service Providers

Sustained release excipients service providers are offering their services through retail channels. Increasing innovative collaborative research opportunities in pediatric formulations is being pushed through evolution of new regulations, additional funding opportunities, and increased public-private partnerships.

This has been focused to development of excipients used in all kinds of excipients such as oral solid dosage formulations and liquid pediatric formulation, which are flexible, dispersible and multi-functional. Furthermore, continued prioritization of unmet medical needs in pediatrics is expected to drive demand for these excipients and oral formulations in the forthcoming years.

Growing Impact of Drug Abuse on Public Health

Substance abuse has high impact on the health of individuals and their families. Prolonged drug and alcohol abuse may lead to mental illness and chronic diseases, such as diabetes and heart diseases, cancer, which in turn, can create high economic burden on the society. In order to curb this economic burden caused by drug abuse, governments are focusing on prevention and early intervention strategies are expected to drive demand for drugs of abuse.

For instance, according to the Centers for Disease Control and Prevention (CDC), nearly 10 million individuals aged 55 and above were reported to seek treatment for cancer across the globe. in 2014. Moreover, it is estimated that nearly US$ 600 Bn is spent on addressing the impact caused by substance abuse each year in the U.S.

Sustained Release Excipients Market

Competitive Landscape

Competition section of the sustained release excipients market features profiles of key players operating in the industry based on their market shares, differential strategies, product offerings, marketing approach and company dashboard. Examples of some of the key players featured in this report include FMC Corporation, Ashland Global Holdings, BASF Corporation, The Dow Chemical Company, Roquette Freres S.A. Colorcon Inc., Croda International Inc.

The key manufacturers of sustained release excipients are focusing on novel marketing strategies to increase product penetration. The companies offering point-of-care sustained release excipients are concentrating on price floor strategies.

These companies are offering their products with lucrative discounts. Conventional distribution channels, such as retail pharmacies, drug stores, supermarkets and hypermarkets are expected to be the key targets channel for local manufacturers.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Definition

The sustained release excipients are one of the type of excipients that are added to the drug along with active pharmaceutical ingredients of medication. Sustained release excipients are pharmacologically non-active ingredients of the drug formulation.

About the Report

The report offers a comprehensive evaluation of the business opportunities prevailing in the sustained release excipients market along with insights on the sustained release excipients consumption trend, disease incidences, and awareness level for sustained release excipients and sustained release excipients market competition. The report elaborates on the macroeconomic factors influencing the dynamics of sustained release excipients market and its futuristic potential.

Additional Questions Answered

Some of the additional questions addressed in this report on sustained release excipients market-

  • What is the revenue potential of the sustained release excipients market across regions of North America and Europe?
  • Who are the key competitors and what are their portfolios in sustained release excipients market?
  • What are major challenges influencing the growth of sustained release excipients market?
  • How intervention from regulatory authority is shaping the sustained release excipients market growth?

Research Methodology

The sustained release excipients market has been estimated based on supply-demand approach. The market was first calculated based on allergy test volume conducted in different region/countries. The test volume was estimated based on the incidence rate of various types of allergies in the top 20 countries globally. Other qualitative factors analyzed during test volume estimation include awareness level for point care sustained release excipients, the recurrence rate of allergy reaction and others.

This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases).

The research study on sustained release excipients market also includes top trends and macro as well as microeconomic factors shaping the sustained release excipients market. With this approach, the report on sustained release excipients market anticipates the industry attractiveness of every major segment in sustained release excipients market over the forecast period.

Segmentation

The report offers a comprehensive taxonomy of sustained release excipients market based on product type, end user, route of administration route, and region. The sustained release excipients are sold for various types of test samples, such as blood, skin, etc. These sustained release excipients are used by pharmaceutical companies, biopharmaceutical companies, neutraceutical companies, and for various type of sustained release excipients, such as food allergies, drug allergies, latex allergies and other types of allergies.

End-use segments in the sustained release excipients market which are a part of this sustained release excipients market report include pharmaceutical companies, biopharmaceutical companies and other end users, such as nutraceutical manufacturers and contract manufacturing organisations. The sustained release excipients market has been analyzed across regions of North America, Latin America, Europe, CIS & Russia, Asia Pacific and MEA.

Frequently Asked Questions

What is the Demand Analysis for Sustained Release Excipients?

Demand for sustained release excipients is likely to grow at a CAGR of 7.5% through 2032.

What is the Major Aspect of the Sustained Release Excipients Market?

Increased benefits over conventional dosage forms and antibiotic resistance.

What is the Adoption Potential of Sustained Release Excipients?

Adoption of sustained release excipients is likely to reach a valuation of US$ 1198.69 Mn in 2022

Who are the Key Participants in the Sustained Release Excipients Market?

FMC Corporation, Ashland Global Holdings, BASF Corporation, The Dow Chemical Company, Roquette Freres S.A. Colorcon Inc., and Croda International Inc.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Definition

    2.2. Market Structure

3. Market Opportunity Analysis

4. Market Analysis Scenario

    4.1. Macro-Economic Factors

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Trends

        4.2.4. Opportunity Analysis

5. Global Economic Outlook

6. North America Market Analysis and Forecast

    6.1. Introduction

    6.2. Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

        6.2.1. U.S.

        6.2.2. Canada

    6.3. Market Value (US$ Mn) Forecast By Country, 2018-2026

    6.4. Historical Market Value (US$ Mn) Analysis By Excipient type, 2013-2017

        6.4.1. Gelatin

        6.4.2. Polymers

        6.4.3. Minerals

        6.4.4. Sugars

        6.4.5. Alcohol

        6.4.6. Chitosan

    6.5. Market Value (US$ Mn) Forecast By Excipient type, 2018-2026

    6.6. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2013-2017

        6.6.1. Oral

        6.6.2. Injectable

        6.6.3. Vaginal

        6.6.4. Ophthalmic

    6.7. Market Value (US$ Mn) Forecast By Route of Administration, 2018-2026

    6.8. Historical Market Value (US$ Mn) Analysis By Distribution Channels, 2013-2017

        6.8.1. Pharmaceutical Companies

        6.8.2. Biopharmaceutical Companies

        6.8.3. Nutraceutical Manufacturers

        6.8.4. Contract Manufacturing Organizations

    6.9. Market Value (US$ Mn) Forecast By Distribution Channels, 2018-2026

    6.10. Drivers and Restraints: Impact Analysis

    6.11. Market Attractiveness Analysis

        6.11.1. By Country

        6.11.2. By Excipient type

        6.11.3. By Route of Administration

        6.11.4. By Distribution Channels

7. Latin America Market Analysis and Forecast

    7.1. Introduction

    7.2. Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

        7.2.1. Brazil

        7.2.2. Mexico

        7.2.3. Rest of Latin America

    7.3. Market Value (US$ Mn) Forecast By Country, 2018-2026

    7.4. Historical Market Value (US$ Mn) Analysis By Excipient type, 2013-2017

        7.4.1. Gelatin

        7.4.2. Polymers

        7.4.3. Minerals

        7.4.4. Sugars

        7.4.5. Alcohol

        7.4.6. Chitosan

    7.5. Market Value (US$ Mn) Forecast By Excipient type, 2018-2026

    7.6. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2013-2017

        7.6.1. Oral

        7.6.2. Injectable

        7.6.3. Vaginal

        7.6.4. Ophthalmic

    7.7. Market Value (US$ Mn) Forecast By Route of Administration, 2018-2026

    7.8. Historical Market Value (US$ Mn) Analysis By Distribution Channels, 2013-2017

        7.8.1. Pharmaceutical Companies

        7.8.2. Biopharmaceutical Companies

        7.8.3. Nutraceutical Manufacturers

        7.8.4. Contract Manufacturing Organizations

    7.9. Market Value (US$ Mn) Forecast By Distribution Channels, 2018-2026

    7.10. Drivers and Restraints: Impact Analysis

    7.11. Market Attractiveness Analysis

        7.11.1. By Country

        7.11.2. By Excipient type

        7.11.3. By Route of Administration

        7.11.4. By Distribution Channels

8. Europe Market Analysis and Forecast

    8.1. Introduction

    8.2. Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

        8.2.1. Germany

        8.2.2. France

        8.2.3. U.K.

        8.2.4. Spain

        8.2.5. Italy

        8.2.6. Rest of Europe

    8.3. Market Value (US$ Mn) Forecast By Country, 2018-2026

    8.4. Historical Market Value (US$ Mn) Analysis By Excipient type, 2013-2017

        8.4.1. Gelatin

        8.4.2. Polymers

        8.4.3. Minerals

        8.4.4. Sugars

        8.4.5. Alcohol

        8.4.6. Chitosan

    8.5. Market Value (US$ Mn) Forecast By Excipient type, 2018-2026

    8.6. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2013-2017

        8.6.1. Oral

        8.6.2. Injectable

        8.6.3. Vaginal

        8.6.4. Ophthalmic

    8.7. Market Value (US$ Mn) Forecast By Route of Administration, 2018-2026

    8.8. Historical Market Value (US$ Mn) Analysis By Distribution Channels, 2013-2017

        8.8.1. Pharmaceutical Companies

        8.8.2. Biopharmaceutical Companies

        8.8.3. Nutraceutical Manufacturers

        8.8.4. Contract Manufacturing Organizations

    8.9. Market Value (US$ Mn) Forecast By Distribution Channels, 2018-2026

    8.10. Drivers and Restraints: Impact Analysis

    8.11. Market Attractiveness Analysis

        8.11.1. By Country

        8.11.2. By Excipient type

        8.11.3. By Route of Administration

        8.11.4. By Distribution Channels

9. CIS & Russia Market Analysis and Forecast

    9.1. Introduction

    9.2. Historical Market Value (US$ Mn) Analysis By Excipient type, 2013-2017

        9.2.1. Gelatin

        9.2.2. Polymers

        9.2.3. Minerals

        9.2.4. Sugars

        9.2.5. Alcohol

        9.2.6. Chitosan

    9.3. Market Value (US$ Mn) Forecast By Excipient type, 2018-2026

    9.4. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2013-2017

        9.4.1. Oral

        9.4.2. Injectable

        9.4.3. Vaginal

        9.4.4. Ophthalmic

    9.5. Market Value (US$ Mn) Forecast By Route of Administration, 2018-2026

    9.6. Historical Market Value (US$ Mn) Analysis By Distribution Channels, 2013-2017

        9.6.1. Pharmaceutical Companies

        9.6.2. Biopharmaceutical Companies

        9.6.3. Nutraceutical Manufacturers

        9.6.4. Contract Manufacturing Organizations

    9.7. Market Value (US$ Mn) Forecast By Distribution Channels, 2018-2026

    9.8. Drivers and Restraints: Impact Analysis

    9.9. Market Attractiveness Analysis

        9.9.1. By Country

        9.9.2. By Excipient type

        9.9.3. By Route of Administration

        9.9.4. By Distribution Channels

10. Asia Pacific Market Analysis and Forecast

    10.1. Introduction

    10.2. Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

        10.2.1. China

        10.2.2. India

        10.2.3. ASEAN

        10.2.4. Australia and New Zealand

        10.2.5. Rest of APEJ

    10.3. Market Value (US$ Mn) Forecast By Country, 2018-2026

    10.4. Historical Market Value (US$ Mn) Analysis By Excipient type, 2013-2017

        10.4.1. Gelatin

        10.4.2. Polymers

        10.4.3. Minerals

        10.4.4. Sugars

        10.4.5. Alcohol

        10.4.6. Chitosan

    10.5. Market Value (US$ Mn) Forecast By Excipient type, 2018-2026

    10.6. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2013-2017

        10.6.1. Oral

        10.6.2. Injectable

        10.6.3. Vaginal

        10.6.4. Ophthalmic

    10.7. Market Value (US$ Mn) Forecast By Route of Administration, 2018-2026

    10.8. Historical Market Value (US$ Mn) Analysis By Distribution Channels, 2013-2017

        10.8.1. Pharmaceutical Companies

        10.8.2. Biopharmaceutical Companies

        10.8.3. Nutraceutical Manufacturers

        10.8.4. Contract Manufacturing Organizations

    10.9. Market Value (US$ Mn) Forecast By Distribution Channels, 2018-2026

    10.10. Drivers and Restraints: Impact Analysis

    10.11. Market Attractiveness Analysis

        10.11.1. By Country

        10.11.2. By Excipient type

        10.11.3. By Route of Administration

        10.11.4. By Distribution Channels

11. MEA Market Analysis and Forecast

    11.1. Introduction

    11.2. Historical Market Value (US$ Mn) Analysis By Country, 2013-2017

        11.2.1. GCC Countries

        11.2.2. South Africa

        11.2.3. Rest of MEA

    11.3. Market Value (US$ Mn) Forecast By Country, 2018-2026

    11.4. Historical Market Value (US$ Mn) Analysis By Excipient type, 2013-2017

        11.4.1. Gelatin

        11.4.2. Polymers

        11.4.3. Minerals

        11.4.4. Sugars

        11.4.5. Alcohol

        11.4.6. Chitosan

    11.5. Market Value (US$ Mn) Forecast By Excipient type, 2018-2026

    11.6. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2013-2017

        11.6.1. Oral

        11.6.2. Injectable

        11.6.3. Vaginal

        11.6.4. Ophthalmic

    11.7. Market Value (US$ Mn) Forecast By Route of Administration, 2018-2026

    11.8. Historical Market Value (US$ Mn) Analysis By Distribution Channels, 2013-2017

        11.8.1. Pharmaceutical Companies

        11.8.2. Biopharmaceutical Companies

        11.8.3. Nutraceutical Manufacturers

        11.8.4. Contract Manufacturing Organizations

    11.9. Market Value (US$ Mn) Forecast By Distribution Channels, 2018-2026

    11.10. Drivers and Restraints: Impact Analysis

    11.11. Market Attractiveness Analysis

        11.11.1. By Country

        11.11.2. By Excipient type

        11.11.3. By Route of Administration

        11.11.4. By Distribution Channels

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Market Structure Analysis

    14.1. Market Structure by Tier

    14.2. Market Share Analysis (2017) for Top Players

    14.3. Product Intensity Mapping by Key Manufacturer

15. Competition Landscape

    15.1. Competition Dashboard

    15.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

        15.2.1. BASF Corporation

        15.2.2. FMC Corporation

        15.2.3. Ashland Global Holdings Inc.

        15.2.4. Roquette Freres S.A

        15.2.5. Colorcon Inc.

        15.2.6. Croda International PLC

        15.2.7. The Dow Chemical Company (DowDuPont)

16. Global Market Analysis and Forecast, By Region

        16.1.1. A detailed, region-wise assessment, providing projections on market growth in key regions

    16.2. Introduction

    16.3. Historical Market Value (US$ Mn) Analysis By Region, 2013-2017

        16.3.1. North America

        16.3.2. Latin America

        16.3.3. Western Europe

        16.3.4. Eastern Europe

        16.3.5. Asia Pacific Excl. CIS & Russia (APEJ)

        16.3.6. CIS & Russia

        16.3.7. Middle East and Africa (MEA)

    16.4. Market Value (US$ Mn) Forecast By Region, 2018-2026

    16.5. Market Attractiveness Analysis By Region

17. Global Market Analysis and Forecast, By Excipient type

    17.1. Introduction

    17.2. Historical Market Value (US$ Mn) Analysis By Excipient type, 2013-2017

        17.2.1. Gelatin

        17.2.2. Polymers

        17.2.3. Minerals

        17.2.4. Sugars

        17.2.5. Alcohol

        17.2.6. Chitosan

    17.3. Market Value (US$ Mn) Forecast By Excipient type, 2018-2026

    17.4. Market Attractiveness Analysis By Excipient type

18. Global Market Analysis and Forecast, By Route of Administration

    18.1. Introduction

    18.2. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2013-2017

        18.2.1. Oral

        18.2.2. Injectable

        18.2.3. Vaginal

        18.2.4. Ophthalmic

    18.3. Market Value (US$ Mn) Forecast By Route of Administration, 2018-2026

    18.4. Market Attractiveness Analysis By Route of Administration

19. Global Market Analysis and Forecast, By Distribution Channels

    19.1. Introduction

    19.2. Historical Market Value (US$ Mn) Analysis By Distribution Channels, 2013-2017

        19.2.1. Pharmaceutical Companies

        19.2.2. Biopharmaceutical Companies

        19.2.3. Nutraceutical Manufacturers

        19.2.4. Contract Manufacturing Organizations

    19.3. Market Value (US$ Mn) Forecast By Distribution Channels, 2018-2026

    19.4. Market Attractiveness Analysis By Distribution Channels

20. Global Market Analysis 2013–2017 and Forecast 2018–2028

    20.1. Market Value Share Analysis By All Segment

    20.2. Y-o-Y Growth Analysis By All Segment

Explore Healthcare Insights

View Reports

Sustained Release Excipients Market